How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
Can SenseWearTM activity monitors detect slow speeds of walking in patients with chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease Year: 2010
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Flow limitation at rest may identify a phenotype of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues Year: 2011
Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Is Hoover‘s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Incidence and time course of expiratory flow limitation (FL) in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
LSC - 2020 - The lung DNA methylation profile of patients with COPD: relationship with smoking and airflow limitation severity. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020